BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/24/2017 2:59:24 AM | Browse: 1305 | Download: 1162
Publication Name World Journal of Stem Cells
Manuscript ID 35363
Country/Territory Switzerland
2017-07-11 05:29
Peer-Review Started
2017-07-14 00:31
To Make the First Decision
2017-08-04 01:58
Return for Revision
2017-08-07 06:57
2017-08-14 13:53
Second Decision
2017-08-28 09:26
Accepted by Journal Editor-in-Chief
2017-08-29 00:21
Accepted by Company Editor-in-Chief
2017-09-04 18:15
Articles in Press
2017-09-04 18:15
Publication Fee Transferred
2017-09-07 09:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-10-23 07:17
Publish the Manuscript Online
2017-10-24 02:59
ISSN 1948-0210 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Minireviews
Article Title Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
Manuscript Source Unsolicited Manuscript
All Author List Ramin Radpour
Author(s) ORCID Number
Ramin Radpour http://orcid.org/0000-0002-5632-7833
Funding Agency and Grant Number
Corresponding Author Ramin Radpour, MSc, PhD, Tumor Immunology and Cancer Stem Cells, Inselspital, Bern University Hospital, Department of Clinical Research, University Hospital Bern, Murtenstrasse 35, Bern 3008, Switzerland. ramin.radpour@dkf.unibe.ch
Key Words Cancer stem cells; Cancer recurrence; Cancer therapy; Combination therapy; Chemotherapy; Radiation therapy; Immunotherapy
Core Tip Cancer stem cells (CSCs) are small subpopulation of the tumor that can survive from conventional treatment, scape from the immune system and can cause recurrence of cancer disease. Therefore, any attempt in detection and selective therapeutic targeting of CSCs will ultimately lead to better cancer treatments and can play an im¬portant role in reducing the cancer related mortalities. This review highlights the trends and approaches in CSC tracing, isolating, characterizing and targeting, which are key strategies for a novel personalized molecular cancer therapy.
Publish Date 2017-10-24 02:59
Citation Radpour R. Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy. World J Stem Cells 2017; 9(10): 169-178
URL http://www.wjgnet.com/1948-0210/full/v9/i10/169.htm
DOI http://dx.doi.org/10.4252/wjsc.v9.i10.169
Full Article (PDF) WJSC-9-169.pdf
Full Article (Word) WJSC-9-169.doc
Manuscript File 35363-Review.docx
Answering Reviewers 35363-Answering reviewers.pdf
Audio Core Tip 35363-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 35363-Conflict-of-interest statement.pdf
Copyright License Agreement 35363-Copyright assignment.pdf
Peer-review Report 35363-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 35363-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 35363-Scientific misconduct check.pdf
Scientific Editor Work List 35363-Scientific editor work list.pdf